| Título: | Neuropsychological Disorders in Patients with Brain Tumor |
| Autores: |
Seddighi, Afsoun; Rajaie Hospital, Qazvin University of Medical Sciences, Qazvin, Iran Seddighi, AS; Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran Ashrafi, F; Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran Nohehsara, S; Psychiatry Department, Iran University of Medical Sciences, Tehran, Iran |
| Fecha: | 2012-04-03 |
| Publicador: | Shahid Beheshti University of Medical Sciences |
| Fuente: |
Ver documento |
| Tipo: |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| Tema: | Brain Tumor; Psychological; Treatment |
| Descripción: | Background: Very few studies have utilized specific criteria to assess mental disorders in brain tumor patients. This study aimed to diagnose mental disorders in this population using DSM-IV (depression, sleep, and mood) criteria. Methods: From March 2007 to July 2009, the surgically treated patients with intracranial neoplasm were included in the study. These patients were examined in an ambulatory neuro-oncology clinic setting using a structured psychiatric interview which followed current DSM-IV diagnostic criteria. Results: This study is based on the clinical data of 89 patients with brain tumor. The mean age was 42.2 years old. Fifty five percent (55 %) of the patients were male. In our study, the prevalence of mild depression was about 30% for males and 38% for females. Before tumor operation, severe anxious as well as severe obsessive-compulsive symptoms were present in 14% of males. In females, 29% of the subjects had reported to have severe anxiousness and 25% severe obsessive symptoms. Conclusion: Depressive symptoms as well as anxious and obsessive psychopathology were shown to be prevalent signs among patients with brain tumor. The associated factors are tumor location, patient’s premorbid psychiatric status, cognitive symptoms and adaptive or maladaptive response to stress.Key Words: Brain Tumor; Psychological; TreatmentReferences 1. Passik SD, Malkin MG, Breitbart WS, Horowitz S. Psychiatric and Psychosocial aspects of neurooncology. J Psychosoc Oncol 1994; 12: 101-22. 2. Salander P, Bergenheim T, Henriksson R .The creation of protection and hope in patients with malignant brain tumours. Soc Sci Med 1996; 42: 985-96. 3. Weitzner MA. Psychosocial and neuropsychiatric aspects of patients with primary brain tumors. Cancer Invest 1999; 17(4):285-91,Review. 4. Scheibel RS, Meyers CA, Levin VA. Cognitive dysfunction following surgery for intraceregral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol 1996; 30: 61-9. 5. Irle E, Peper M, Wowra B, Kunze S. Mood changes after surgery for tumors of the cerebral cortex. Arch Neurol 1994; 51: 164-74. 6. Weitzner MA, Meyers CA. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psycho- Oncology 1997; 6: 169-77. 7. Aiken RD. Quality-of-life issues in patients with malignant gliomas. Semin Oncol 1994; 21: 273- 5. 8. Lovely MP. Quality of life of brain tumor patients. Semin Oncol Nurs 1988; 14: 73-80. 9. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity and guidelines. J Clin Oncol 1984; 2: 180-93. 10. Haines A, Cooper J, Meade TW. Psychological characteristics and fatal ischaemic heart disease. Heart 2001; 85: 385-9. 11. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988; 8: 77-100. 12. Weitzner MA. Psychosocial and neuropsychiatric aspects of patients with primary brain tumors. Cancer Invest 1999; 17: 285-91. 13. Fox S. Use of Quality of life instrument to improve assessment of brain tumor patients in outpatient setting. J Neurosci Nurs 1998; 30: 322-5. 14. Horrobin DF, Bennet CN. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Prostaglandins Leukotri Essent Fatty Acids 1999; 60: 217-34. 15. Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, et al. Depression after stroke and lesion location: a systematic review. Lancet 2000; 356: 122-6. 16. Anderson SW, Damasio H , Tranel D. Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol 1990; 47: 397-405. 17. Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neurooncol 2001; 3: 152-8. 18. Price TRP, Goetz KL, Lowell MR. Neuropsychaitric aspects of brain tumors, American Psychiatric Textbook of Neuropsychiatry, 2nd Edition. Edited by Yudofsky SC, Hales RE. Washington DC, American Psychiatric Press 1992; 473-97. 19. Spiegel D. Cancer and depression. Br J Psych 1996; 168: 109-116. 20. Spiegel D, Giese-Davis J. Depression and cancer: Mechanisms and disease progression. Biol Psychiatry 2003; 54: 269-82. 21. Evans DL, Charney DS. Mood disorders and medical illness: A major public health problem. Biol Psychiatry 2003; 54: 177-80. 22. Hollander E, Kwon JH, Stein DJ, Broatch J, Rowla CT , Himmelein CA. Obsessive compulsive and spectrum disorders: overview and quality of life issues. J Clin Psychiatry 1996; 57 (suppl 8): 3-6. 23. Pelletier G, Verhoef MJ, Khatri N , Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neuro oncol 2002; 57: 41- 9. |
| Idioma: | Inglés |
1 Health and Education - 2 por Akbari, Mohammad Esmaeil | 6 Effectiveness of Mindfulness-Based Cognitive Therapy on Reduction of Depression and Anxiety Symptoms in Mothers of Children With Cancer por Mehranfar, Mojtaba; Dept. of Counselling, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran,Younesi, Jalal; Dept. of Counselling, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran,Banihashem, Abdollah; Dept. of Internal Medicine and Paediatrics, University of
Medical Sciences, Mashhad, Iran |
2 The Study of DNA Methylation of bax Gene Promoter in Breast and Colorectal Carcinoma Cell Lines por Alipour, Mohsen; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Zargar, Seyed Jalal; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Safarian, Shahrokh; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Fouladdel, Shamile; Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran,Azizi, Ebrahim; Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran,Jafargholizadeh, Naser; Dept. of Cell & Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran | 7 Prevention and Management of Mucositis in Patients With Cancer: a Review Article por [wlia, ّatemeh; Dept. of Oral Medicine, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran,«azemeini, ُeidkazem; Burn hospital, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran,gholami, neda; Dept. of Oral Medicine, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran |
3 Cancer Prevention; Cancer Risk Management por Akbari, Mohammad Esmaeil | 8 Psychosocial Care for Breast Cancer: Physicians' Perspective por Kaviani, Ahmad; Department of surgery, Tehran University of Medical Sciences, Tehran, Iran,Mehrdad, N; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Yunesian, M; school of Public Health , Environmental Research Center, Tehran University of Medical Sciences, Tehran, Iran,Shakiba, B; Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran,Ebrahimi, M; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Majidzadeh, K; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Akbari, ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
4 Euthanasia in Cancer Patients, Islamic Point of View por Mousavi, SM; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Akbari, A; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Akbari, ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Najd Sepas, H; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran | 9 Cell Survival Entropy and Cellular Resistance Activation Dose: Effect of Calprotectin on Gastric Adenocarcinoma Cell Line por Rezaei-Tavirani, Mostafa,Rahmati-Roodsari, Mohammad,Mirzaie, Mehdi,Amini Geram, Pooneh,Sobhi, Sara |
5 Evaluation of Prognostic Factors In Patients with Metastatic Breast Cancer por Saeidi Saedi, H,Seilanian Toosi, M,Mirsadraei, M,Roodbari, S | 10 Antiphospholipid Antibodies in Neoplastic Patients por Mortazavizadeh, MR,Sadeghmanesh, R |